Form 4: Pfizer Director James Quincey Acquires Phantom Stock Units as Deferred Compensation

Director James Quincey acquired 8,999 phantom stock units of Pfizer as part of a deferred compensation plan.

Summary

• On April 24, 2025, James Quincey, a director of Pfizer Inc., acquired 8,999 phantom stock units.
• The acquisition was made pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
• Each unit represents one phantom share of Pfizer common stock.
• These units represent deferred director's compensation that will be settled in cash or common stock at the director's election following retirement from the Board of Directors.
• Following the transaction, Quincey beneficially owns 66,442.047 phantom stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The use of deferred compensation is a common practice, suggesting sound corporate governance.

Positives

• The acquisition of phantom stock units aligns the director's interests with those of the shareholders.
• Deferred compensation plans can be tax-efficient for both the company and the director.

Future Outlook

The phantom stock units will be settled in cash or common stock at the director's election following retirement from the Board of Directors.

Industry Context

Deferred compensation plans are a common practice for compensating non-employee directors in publicly traded companies, aligning their interests with long-term shareholder value.

Comparison to Industry Standards

• Pfizer's director compensation practices, including the use of phantom stock units, are generally in line with those of other large pharmaceutical companies such as Johnson & Johnson and Merck.
• These companies often use a mix of cash, stock options, and deferred compensation to attract and retain qualified board members.
• The specific terms of these plans, such as vesting schedules and settlement options, can vary.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, employees, customers, suppliers, or creditors.
• It primarily affects the director's compensation and alignment with shareholder interests.

Key Dates

Keywords

Form 4, Pfizer, James Quincey, Phantom Stock Units, Deferred Compensation, Director, Beneficial Ownership